Myomo (MYO) Operating Income (2016 - 2025)
Myomo's (MYO) quarterly Operating Income came in at -$3.5 million in Q3 2025, down 267.34% on a YoY basis from $2.1 million in Q3 2024, and up 23.37% quarter-over-quarter from -$4.6 million in Q2 2025.
Analysis
Myomo (MYO) Operating Income (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Operating Income for 10 consecutive years, with -$3.5 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Operating Income fell 267.34% year-over-year to -$3.5 million; the trailing twelve-month figure through Sep 2025 stood at -$11.9 million (down 41.44% YoY), and the FY2024 full-year result was -$6.2 million, up 24.6% from the prior year.
- Operating Income climbed to -$3.5 million in Q3 2025 per MYO's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$245314.0 in Q4 2024 and bottomed at -$4.6 million in Q2 2025.
- Historically, Operating Income has averaged -$2.5 million across 5 years, with a median of -$2.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Income soared 89.92% in 2024, then tumbled 311.66% in 2025.
- Over 5 years, Operating Income stood at -$2.7 million in 2021, then gained by 17.61% to -$2.2 million in 2022, then retreated by 9.14% to -$2.4 million in 2023, then jumped by 89.92% to -$245314.0 in 2024, then slumped by 1333.88% to -$3.5 million in 2025.
- According to Business Quant data, Operating Income over the past three periods registered -$3.5 million, -$4.6 million, and -$3.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.82 Bn | 177.22 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 123.46 Bn | 118.24 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 105.55 Bn | 102.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 64.84 Bn | 64.30 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.45 Bn | 45.19 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 33.15 Bn | 31.70 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 31.78 Bn | 29.83 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3.52 Mn |
| Jun 30, 2025 | -4.59 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | -245,314.00 |
| Sep 30, 2024 | -957,553.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.89 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | -1.10 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Sep 30, 2022 | -2.82 Mn |
| Jun 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | -2.74 Mn |
| Dec 31, 2021 | -2.71 Mn |
| Sep 30, 2021 | -2.03 Mn |
| Jun 30, 2021 | -2.60 Mn |
| Mar 31, 2021 | -2.93 Mn |
| Dec 31, 2020 | -1.69 Mn |